Physician profile
Andrew Walker
NPI 1306227384
$6,680.54
in general payments reported to CMS, 2019-2025
10 companies · $300 in 2025
The $300 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $173 · 2022: $2,561 · 2023: $2,698 · 2024: $948 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,402 · Travel and Lodging: $786 · Education: $750 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,402.34 |
| Travel and Lodging | $785.60 |
| Education | $750.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,218.28 | 2022-2025 | Da Vinci Surgical System, Davinci Xi |
| Integra Lifesciences Corporation | $1,859.22 | 2021-2022 | |
| Kerecis Limited | $610.58 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Abbvie INC. | $507.17 | 2023-2025 | Strattice Reconstructive Tissue Matrix Bps, Alloderm |
| Bone Support INC. | $129.13 | 2024 | Ceramentbone Void Filler, Cerament G |
| Boston Scientific Corporation | $119.51 | 2023 | Spyglass |
| Kci USA, INC. | $92.83 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $85.27 | 2022 | |
| Tela Bio, INC. | $30.56 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Innocoll Pharmaceuticals Limited | $27.99 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.